Correction to: Gene Therapy (2005) 12, 196–202. doi:10.1038/sj.gt.3302416
Since publication of the above article, the authors have identified an error in the authorship of the paper. The correct authorship is shown below.
L Zhou1, W Ma1*, Z Yang1, F Zhang1, L Lu1, Z Ding1, B Ding1, T Ha1, X Gao2*, C Li1,3*
1Department of Cardiology, the first affiliated hospital, Nanjing Medical University, Nanjing, China
2Model Animal Research Center, Nanjing University, Nanjing, China
3Department of Surgery, Quillen College of Medicine, East Tennessee State University, USA
*Corresponding authors:Wenzhu Ma, MD. Leizhou1234@sina.com
Xiang Gao, PhD. gaoxiang@nju.edu.cn
Chuanfu Li, MD. li@access.etsu.edu
This study was supported by the National Institutes of Health (NIH) Grant RO1 HL-071837 (to C Li) and National Gongguan Project of China Grant 2001BA710B (to X Gao).
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at 10.1038/sj.gt.3302416
Rights and permissions
About this article
Cite this article
Zhou, L., Ma, W., Yang, Z. et al. Correction: Corrigendum to VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 12, 552 (2005). https://doi.org/10.1038/sj.gt.3302501
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302501
